Six essential conditions for bladder-sparing strategies in bacillus Calmette-Guérin unresponsive bladder cancer
Shariat Sh., Enikeev D. V., Mostafaei H.
Immunotherapy
Vol.11, Issue13, P. 1083-1086
Опубликовано: 2019
Тип ресурса: Редакционная статья
DOI:10.2217/imt-2019-0083
Аннотация:
[краткое описание не найдено]
Ключевые слова:
bacillus Calmette-Guérin; BCG unresponsive; bladder cancer; immunotherapy; non muscle invasive bladder cancer; salvage therapies
BCG vaccine; BCG vaccine; immunological adjuvant; bladder cancer; cancer immunotherapy; consensus development; cystectomy; drug efficacy; drug tolerability; Editorial; health care cost; human; medical society; muscle invasive bladder cancer; non muscle invasive bladder cancer; patient safety; practice guideline; priority journal; salvage therapy; transitional cell carcinoma; treatment outcome; bladder tumor; cytotoxicity; immunology; immunotherapy; procedures; tumor microenvironment; Adjuvants, Immunologic; BCG Vaccine; Cytotoxicity, Immunologic; Humans; Immunotherapy; Salvage Therapy; Tumor Microenvironment; Urinary Bladder Neoplasms
Язык текста: Английский
ISSN: 1750-7448
Shariat Sh. Sharokh 1973-
Enikeev D. V. Dmitrij Viktorovich 1982-
Mostafaei H.
Шариат Ш. Шарох 1973-
Еникеев Д. В. Дмитрий Викторович 1982-
Мостафаеи Х.
Six essential conditions for bladder-sparing strategies in bacillus Calmette-Guérin unresponsive bladder cancer
Текст визуальный непосредственный
Immunotherapy
Vol.11, Issue13 P. 1083-1086
2019
Редакционная статья
bacillus Calmette-Guérin BCG unresponsive bladder cancer immunotherapy non muscle invasive bladder cancer salvage therapies
BCG vaccine BCG vaccine immunological adjuvant bladder cancer cancer immunotherapy consensus development cystectomy drug efficacy drug tolerability Editorial health care cost human medical society muscle invasive bladder cancer non muscle invasive bladder cancer patient safety practice guideline priority journal salvage therapy transitional cell carcinoma treatment outcome bladder tumor cytotoxicity immunology immunotherapy procedures tumor microenvironment Adjuvants, Immunologic BCG Vaccine Cytotoxicity, Immunologic Humans Immunotherapy Salvage Therapy Tumor Microenvironment Urinary Bladder Neoplasms
[краткое описание не найдено]